[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f2rbqX1wTBxJshauqbFELR0Qm60RR2OxD7R_JON67vuY":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":20,"related":21,"source":32,"type":33},[],"2026-05-21 09:43:43",380394907,[8,9,10,11,12],"全血","新鲜冰冻血浆","VIⅢ因子浓缩剂","冷沉淀","悬浮红细胞",{"count":14,"courseId":15,"courseImg":16,"courseName":17,"workId":18,"workName":19},81,"295476882842784d91dfca0a2d29c368","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F10baf5bc3eee9ea2707da3b904acb974.jpg","临床输血学检验技术","work_53422318","临床输血与自体输血(2026)","血管性血友病患者,补充vWF应选择( )",[22,34,42,52,55,65,71,77,87,97],{"answer":23,"createTime":5,"id":24,"options":25,"question":31,"source":32,"type":33},[],380394903,[26,27,28,29,30],"临床上有效且能够提供最大安全性的血细胞","临床上有效且能够提供最大安全性的血浆","临床上有效且能够提供最大安全性的血浆制品","虽然不是最安全,但临床上有效的某一种血液成分","临床上有效且能够提供最大安全性的某一种血液成分","患者应该尽可能只接受( )","v1",0,{"answer":35,"createTime":5,"id":36,"options":37,"question":41,"source":32,"type":33},[],380394904,[8,12,38,39,40],"洗涤红细胞","少白细胞红细胞","辐照红细胞","患者女,32岁.因贫血需输血治疗,实验室检查结果为RBC 1.6&times;10&sup1;2\u002FL,Hb 52g\u002FL,HCt 15.4%,既往史显示患者曾对血浆蛋白有过敏反应.此患者应输何种血液成分( )",{"answer":43,"createTime":5,"id":44,"options":45,"question":51,"source":32,"type":33},[],380394906,[46,47,48,49,50],"输注红细胞","输注全血","祛除病因","补充铁剂","补充VitC","缺铁性贫血患者首选的治疗方案是( )",{"answer":53,"createTime":5,"id":6,"options":54,"question":20,"source":32,"type":33},[],[8,9,10,11,12],{"answer":56,"createTime":5,"id":57,"options":58,"question":64,"source":32,"type":33},[],380394909,[59,60,61,62,63],"治疗疾病","缓解贫血症状","提高血红蛋白值达到正常水平","提高血细胞比容达到正常水平","提高机体免疫力","慢性贫血输注悬浮红细胞的主要目的是( )",{"answer":66,"createTime":5,"id":67,"options":68,"question":70,"source":32,"type":33},[],380394910,[8,12,40,38,69],"低温保存红细胞","有免疫缺陷或免疫抑制的患者需输注红细胞制剂时,应尽量输注( )",{"answer":72,"createTime":5,"id":73,"options":74,"question":76,"source":32,"type":33},[],380394912,[12,75,39,8,38],"辐照悬浮红细胞","血红蛋白低于60g\u002FL的慢性贫血患者,输血治疗时通常选择( )",{"answer":78,"createTime":5,"id":79,"options":80,"question":86,"source":32,"type":33},[],380394914,[81,82,83,84,85],"急性白血病患者","慢性白血病患者","特发性血小板减少性紫癜患者","DIC患者","急性再生障碍性贫血患者","输注冷沉淀的主要适应证是( )",{"answer":88,"createTime":5,"id":89,"options":90,"question":96,"source":32,"type":33},[],380394915,[91,92,93,94,95],"外周血粒细胞计数增加","患者体温正常","患者尿量增加","患者体温下降,感染被控制","血压升高","临床输注粒细胞有效的判断标准是( )",{"answer":98,"createTime":5,"id":99,"options":100,"question":102,"source":32,"type":33},[],380394918,[8,12,101,9,11],"单采血小板","输血申请单中输血目的为纠正贫血,申请备血的血液成分应为( )"]